BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6815193)

  • 1. Isolation and functional properties of the heavy and light chains of human plasma kallikrein.
    van der Graaf F; Tans G; Bouma BN; Griffin JH
    J Biol Chem; 1982 Dec; 257(23):14300-5. PubMed ID: 6815193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
    Kerbiriou DM; Bouma BN; Griffin JH
    J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI.
    van der Graaf F; Greengard JS; Bouma BN; Kerbiriou DM; Griffin JH
    J Biol Chem; 1983 Aug; 258(16):9669-75. PubMed ID: 6604052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat plasma high-molecular-weight kininogen. A simple method for purification and its characterization.
    Hayashi I; Kato H; Iwanaga S; Oh-ishi S
    J Biol Chem; 1985 May; 260(10):6115-23. PubMed ID: 3846594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
    Veloso D; Silver LD; Hahn S; Colman RW
    Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties.
    Colman RW; Wachtfogel YT; Kucich U; Weinbaum G; Hahn S; Pixley RA; Scott CF; de Agostini A; Burger D; Schapira M
    Blood; 1985 Feb; 65(2):311-8. PubMed ID: 3871342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.
    van der Graaf F; Rietveld A; Keus FJ; Bouma BN
    Biochemistry; 1984 Apr; 23(8):1760-6. PubMed ID: 6202319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contact activation mechanism in human plasma: activation induced by dextran sulfate.
    van der Graaf F; Keus FJ; Vlooswijk RA; Bouma BN
    Blood; 1982 Jun; 59(6):1225-33. PubMed ID: 6177360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.
    Kerbiriou DM; Griffin JH
    J Biol Chem; 1979 Dec; 254(23):12020-7. PubMed ID: 500690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human plasma kallikrein. Immunoreactivity and activity on natural and synthetic substrates.
    Motta G; Sampaio CA; Sampaio MU
    Agents Actions Suppl; 1992; 36():200-8. PubMed ID: 1609643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proenzyme from chicken plasma similar to human plasma prekallikrein.
    Schleuning WD; Sudol M; Reich E
    J Biol Chem; 1983 Dec; 258(23):14106-15. PubMed ID: 6557113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of prekallikrein from porcine plasma and its conversion to active kallikrein.
    Kikuno Y; Takahashi H; Suzuki T
    J Biochem; 1983 Jan; 93(1):235-41. PubMed ID: 6551387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.